Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Renal Cell Carcinoma ( mRCC)”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Not applicableStudy completedNCT03161145
What this trial is testing

Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 297
Early research (Phase 1)Study completedNCT02406521
What this trial is testing

Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Mets

Who this might be right for
Metastatic Renal Cell Carcinoma
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)UnknownNCT01274273
What this trial is testing

Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Aarhus 118
Large-scale testing (Phase 3)Active Not RecruitingNCT01224288
What this trial is testing

Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 120
Not applicableActive Not RecruitingNCT04919122
What this trial is testing

Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Duke University 468
Testing effectiveness (Phase 2)Study completedNCT03967522
What this trial is testing

Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases

Who this might be right for
Metastatic Renal Cell Carcinoma
Centre Leon Berard 26
Testing effectiveness (Phase 2)Ended earlyNCT01342627
What this trial is testing

Sorafenib in Elderly Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Centro di Riferimento Oncologico - Aviano 4
Not applicableNot Yet RecruitingNCT07233668
What this trial is testing

Immediate Versus Deferred Cytoreductive Nephrectomy With Ipilimumab/Nivolumab in mRCC

Who this might be right for
Metastatic Renal Cell Carcinoma ( mRCC)
Seoul National University Hospital 172
Not applicableStudy completedNCT03891485
What this trial is testing

Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy

Who this might be right for
RCCMetastatic Renal Cell Carcinoma
National Cancer Institute, Naples 200
Testing effectiveness (Phase 2)Looking for participantsNCT07227415
What this trial is testing

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Who this might be right for
Carcinoma, Renal CellAdvanced Renal Cell CarcinomaRenal Cancer+10 more
Pfizer 224
Testing effectiveness (Phase 2)Ended earlyNCT02447887
What this trial is testing

Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC)

Who this might be right for
Metastatic Renal Cell CarcinomaRCC
Fox Chase Cancer Center 3
Not applicableStudy completedNCT01598597
What this trial is testing

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

Who this might be right for
Breast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more
Genentech, Inc. 276
Not applicableStudy completedNCT05363072
What this trial is testing

Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.

Who this might be right for
Renal Cell CancerRenal Cell CarcinomaCancer of Kidney+4 more
Pfizer 1,112
Testing effectiveness (Phase 2)Study completedNCT01829841
What this trial is testing

Famitinib in Patients With Advanced Metastatic Renal Cell Cancer

Who this might be right for
Renal Cell CancerMetastatic Renal Cell Cancer
Jiangsu HengRui Medicine Co., Ltd. 150
Large-scale testing (Phase 3)Study completedNCT02853331
What this trial is testing

Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 861
Testing effectiveness (Phase 2)Study completedNCT00085436
What this trial is testing

DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC

Who this might be right for
Kidney Cancer
Dartmouth-Hitchcock Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT01731158
What this trial is testing

Sequential Therapy in Metastatic Renal Cell Carinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Central European Society for Anticancer Drug Research 22
Testing effectiveness (Phase 2)Study completedNCT02599779
What this trial is testing

A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients

Who this might be right for
Stage IV Renal Cell Cancer AJCC V7
Sunnybrook Health Sciences Centre 4
Early research (Phase 1)Study completedNCT01152801
What this trial is testing

Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 64
Not applicableStudy completedNCT04115189
What this trial is testing

A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA)

Who this might be right for
Metastatic Renal Cell Carcinoma ( mRCC)
Pfizer 57
Next Page